论文部分内容阅读
哺乳期乳腺炎的发生与乳汁分泌密切相关,为了提高疗效,必须抑制乳汁分泌。本文研究甲磺酸溴隐亭在哺乳期乳腺炎综合治疗中的作用。患者31例,其中浸润-浆液型6例,脓肿型3例,浸润-化脓型20例,纯乳腺炎2例。对化脓型乳腺炎患者先进行手术,并用抗生素、血液制剂、免疫增强剂、维生素和抗组胺药治疗,然后口服本品2.5 mg,第1、2天每日3次,第3天起每日2次。患者入院时乳汁明显郁滞,治疗后症状消失,泌乳完全停止。为维持作用,必须连续使用本品3～4周。本试验与不用本品的20例乳腺炎患者对照表明,达开始抑乳所需的平均住院日前者为12.3±2.8天,后者27.7±3.9天(p<0.01)。
The occurrence of lactating mastitis and milk secretion are closely related, in order to improve the efficacy, we must inhibit milk secretion. This article studies the role of bromocriptine mesylate in the comprehensive treatment of lactating mastitis. There were 31 patients, including 6 infiltration-serous type, 3 abscess type, 20 infiltrate-suppurative type and 2 pure mastitis. For patients with suppurative mastitis first surgery, and antibiotics, blood preparations, immune enhancers, vitamins and antihistamines, and oral administration of this product 2.5 mg, 1, 2 days 3 times a day from the first 3 days 2 times a day. Patients admitted to the hospital was significantly stagnant milk, symptoms disappeared after treatment, lactation completely stopped. To maintain the role, we must continue to use this product 3 to 4 weeks. The comparison of this study with 20 mastitis patients who did not use this product showed that the average length of stay required to start deprivation was 12.3 ± 2.8 days before and 27.7 ± 3.9 days for the latter (p <0.01).